Results 1 to 10 of about 1,254,223 (252)
Mucinous breast carcinoma with neuroendocrine differentiation: Case report
Clinical Case Reports, 2022 Mucinous carcinoma of the breast is rare representing 2% of all breast carcinomas. It can be classified as either a pure or a mixed type. Pure mucinous breast carcinoma has a less aggressive behavior compared with mixed breast mucinous carcinoma.
Faten Limaiem, Saadia Bouraoui
doaj +1 more source
Male Breast Cancer: A Rare Entity
Journal of Nepal Medical Association, 2018 Male breast carcinoma is a rare malignancy (
Swotantra Gautam +4 more
doaj +1 more source
Mixed Mucinous Male Breast Carcinoma: A Rare Histological Variant of a Rare Disease [PDF]
Journal of Clinical and Diagnostic Research, 2018 Male breast carcinoma is rare neoplasm, accounting for
Badareesh Lakshminarayana +3 more
doaj +1 more source
Advanced Biomedical Research, 2014 Background: The association between Epstein-Barr virus (EBV) and breast carcinoma in Iranian women is uncertain. We examined EBV latent membrane protein-1 (LMP-1) antigen expression in breast carcinoma and its relationship with clinicopathologic ...
Fereshteh Mohammadizadeh +2 more
doaj +1 more source
Invasive Papillary Carcinoma of the Male Breast Misdiagnosed as Fibroadenoma on FNAB [PDF]
Journal of Clinical and Diagnostic Research, 2017 Male breast cancers constitute less than 1% of all the breast cancers. Papillary carcinoma is a very rare tumour of the male breast. Due to rarity, Fine Needle Aspiration Biopsy (FNAB) findings of papillary carcinoma in male breast are seldom reported ...
Richa Katiyar +3 more
doaj +1 more source
Atypical Breast Carcinoma- A Series of Six Cases [PDF]
Journal of Clinical and Diagnostic Research, 2022 Breast cancer comprises 10.4% of all cancer among women world and it the second most common type of cancer. Increased public awareness and screening have led to earlier diagnosis at different stages.
Smritiparna Das, Chhanda Das, Rama Saha
doaj +1 more source
Expression of VEGF-C in Breast Carcinoma and its Association with HER2/neu and Oestrogen/Progesterone Receptors: A Cross-sectional Study [PDF]
National Journal of Laboratory Medicine, 2023 Introduction: Breast carcinoma is the most common malignant tumour and is the leading cause of carcinoma death in women. Assessing Vascular Endothelial Growth Factor-C (VEGF-C) is important because the expression of VEGF-C is one of the factors ...
Sohini Ray, Suman Ghosh, Sritanu Jana
doaj +1 more source
BMC Medicine, 2020 Background Wide implementation of mammography screening has resulted in increased numbers of women diagnosed with breast carcinoma in situ. We aimed to determine the risk of invasive breast cancer in relatives of patients with breast carcinoma in situ in
Trasias Mukama +6 more
doaj +1 more source
Indian Journal of Pathology and Microbiology, 2023 Metastasis from non-mammary malignant neoplasms to the breast is rare and represents 0.2%-1.3% of all breast malignancies. Fine needle aspiration cytology (FNAC) is the first line of investigation for any breast lump and cyto-morphological appearance of ...
Nibedita Sahoo +3 more
doaj +1 more source
Mucinous Cystadenocarcinoma Coexisting with Invasive Ductal Carcinoma of the Breast: A Rare Case Report [PDF]
Journal of Clinical and Diagnostic Research, 2023 Mucinous Cystadenocarcinoma (MCA) of the breast is a rare variant of primary breast cancer with an unknown aetiology and pathogenesis. It resembles MCA of the ovary and pancreas and accounts for about one to four percent of primary breast cancers. Less
Sandeep Mani, Swetha Lakshmi Narla
doaj +1 more source